Robin Murdock, APRN
Payments from drug & device makers
Across 199 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$737
- Collegium Pharmaceutical, Inc.$691
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$249
- Teva Pharmaceuticals USA, Inc.$244
- Avanir Pharmaceuticals, Inc.$232
- Amgen$209
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,651100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $737 |
| Collegium Pharmaceutical, Inc. | 62 | $691 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $249 |
| Teva Pharmaceuticals USA, Inc. | 11 | $244 |
| Avanir Pharmaceuticals, Inc. | 8 | $232 |
| Amgen(2 entities) | 10 | $209 |
| Arbor Pharmaceuticals, Inc. | 7 | $140 |
| Painteq LLC | 4 | $135 |
| Upsher-smith Laboratories LLC | 7 | $132 |
| Vertos Medical, Inc. | 1 | $111 |
| Pfizer | 4 | $109 |
| Lilly USA, LLC | 5 | $102 |
| Scilex Pharmaceuticals Inc. | 5 | $95 |
| Azurity Pharmaceuticals, Inc. | 4 | $88 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $79 |
| Biohaven Pharmaceuticals, Inc. | 3 | $62 |
| Almatica Pharma LLC | 2 | $43 |
| Boston Scientific | 2 | $37 |
| Medtronic | 1 | $29 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Vertex | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Cumberland Pharmaceuticals, Inc. | 1 | $18 |
| Impel Pharmaceuticals Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$111
How this compares
$3,657 in reported general payments places this provider in the 90th percentile of 1,596 family providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 56 | $52,297 |
| RelistorMethylnaltrexone Bromide | 13 | $32,559 |
| Buprenorphine | 84 | $18,630 |
| Levorphanol Tartrate | 13 | $16,234 |
| Oxycodone Hcl | 715 | $14,451 |
| ZtlidoLidocaine | 21 | $12,880 |
| MovantikNaloxegol Oxalate | 29 | $11,788 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 392 | $10,530 |
| Xtampza ErOxycodone Myristate | 27 | $10,427 |
| LinzessLinaclotide | 16 | $8,631 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 125 | $5,078 |
| Tizanidine Hcl | 181 | $3,521 |
| Pregabalin | 99 | $2,720 |
| Tramadol Hcl ErTramadol Hcl | 30 | $2,497 |
| Morphine Sulfate ErMorphine Sulfate | 65 | $2,109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $691 | $62,72483 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $249 | $32,55913 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine Hcl, Buprenorphine-Naloxone, Morphine Sulfate | $19 | $20,982144 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $95 | $12,88021 claims |
| Redhill Biopharma Inc.Movantik | $16 | $11,78829 claims |
| AbbVieLinzess | $737 | $8,63116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,596 family providers in Connecticut.
Other family in Derby
- Diana BytyqiDerby$53K
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Dayna GiordanoNew Haven$65K
- Farhiya AbdiSouth Windsor$30K
- Nicole SandilandsBridgeport$30K
- Ralph HirschfeldPutnam$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.